Data / Form D filings / Revalesio Corp
Revalesio Corp: Form D filings
Revalesio Corp, a pharmaceuticals company in Tacoma, WA, filed 8 Form D notices with the SEC between 2012 and 2025. The latest, on December 16, 2025, reports $38.9 million sold of a $40.3 million offering to 31 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1202 E. D ST, Tacoma, WA, 98421
- Phone
- (253) 922-2600
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1552377
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | Amendment | $40,300,000 | $38,877,508 | $1,422,492 | 31 | May 25, 2022 | sec.gov |
| Apr 12, 2024 | Amendment | $30,600,000 | $25,510,205 | $5,089,795 | 31 | May 25, 2022 | sec.gov |
| Jun 9, 2022 | New notice | $15,003,000 | $12,002,400 | $3,000,600 | 20 | May 25, 2022 | sec.gov |
| Jul 22, 2020 | New notice | $26,771,147 | $20,371,187 | $6,399,960 | 22 | Jul 8, 2020 | sec.gov |
| Jun 27, 2018 | New notice | $12,002,400 | $6,000,000 | $6,002,400 | 6 | Jun 15, 2018 | sec.gov |
| Jul 5, 2016 | New notice | $13,999,912 | $13,999,912 | 11 | Jun 23, 2016 | sec.gov | |
| May 5, 2014 | New notice | $40,000,000 | $13,500,000 | $26,500,000 | 3 | Apr 21, 2014 | sec.gov |
| Jun 19, 2012 | New notice | $20,000,000 | $10,650,000 | $9,350,000 | 18 | Jun 6, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| JAMES NORDSTROM | Director | |
| ERIC RUSSELL | Director | |
| GREG ARCHAMBEAU | Executive Officer | |
| CHRIS FIBIGER | Director | |
| BERT VAN DEN BERGH | Director | |
| JANE TAYLOR | Director | |
| MATT IRELAND | Director |
Other pharmaceuticals companies in Washington that filed recently
- Aptevo Therapeutics Inc. $3.5 million · Aug 26, 2026
Every Form D from the week of Dec 15, 2025 · All recent filings in Washington · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Revalesio Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.